CME BREAKFAST PROGRAM │ 7:00 am – 8:00 am

7:00 am – 8:00 am
Diabetic Macular Edema: The Multimodal Movement Toward Real-Life Management
Supported by Allergan, Inc.

GENERAL SESSIONS │ 8:00 am – 11:45 am

Welcome

8:00 am – 8:10 am
Announcements and Pretest
Tarek S. Hassan, MD

Trauma and Proliferative Vitreoretinopathy Surgery

Session Chairs: Tarek S. Hassan, MD; Virgilio Morales-Canton, MD
8:10 am – 8:17 am
Re-examination of the Role of Relaxing Retinotomy in PVR Detachment Repair
Grazia Pertile, MD
8:17 am – 8:24 am
Severe Trauma Cases: Pearls and Tricks
Carl C. Claes, MD
8:24 am – 8:31 am
Ocular Trauma: New Updates
Sundaram Natarajan, MD
8:31 am – 8:38 am
Pharmaceutical Management of PVR
Demetrios G. Vavvas, MD, PhD
8:38 am – 8:45 am
Is Scleral Buckling Necessary?
Gaurav K. Shah, MD
8:45 am – 8:52 am
Management of Subretinal Perfluorocarbon Liquid
Leonardo Bruno de Oliveira, MD
8:52 am – 8:59 am
Use Perfluorocarbon as a Tamponade Agent
Stanislao Rizzo, MD
8:59 am – 9:06 am
Treatment of Persistent Hypotony in PVR Eyes
Tarek S. Hassan, MD
9:06 am – 9:13 am
Strategy for the Primary PVR Surgery
Motohiro Kamei, MD, PhD

Abstract Winners

9:13 am – 9:16 am
Comparative Assessment of Conventional Microscope-integrated Intraoperative OCT to Digitally-enabled
Natalia Figueiredo, MD
9:16 am – 9:19 am
Plasma Rich in Growth Factors (PRGF) for Recurrent Macular Hole Closure: A Pilot Study
Juan Arias, MD
9:19 am – 9:22 am
24 Eyes Presumed Cluster Noninfectious Endophthalmitis After One Day Intravitreal Injections Bevacizumab Off Label. Piura-Peru. 2017.
Victor Alva, MD

Panel Discussion

9:25 am – 9:45 am
Trauma and Proliferative Vitreoretinopathy Surgery
Moderator: Nur Acar Gocgil, MD, Prof, FEBO
Panelists: Ernesto Bali, MD; Carl C. Claes, MD; Ehab N. El Rayes, MD, PhD; Matteo Forlini, MD; Cesare Mariotti, MD; Sundaram Natarajan, MD; Stanislao Rizzo, MD; Ashraf Shaarawy, MD

Refreshment Break

9:45 am – 10:05 am
Refreshments in the Exhibit Hall

Medical Retina: Diabetic Macular Edema and Diabetic Retinopathy

Session Chairs: Ehab N. El Rayes, MD, PhD; Baruch D. Kuppermann, MD, PhD
10:05 am – 10:08 am
Pretest
Ehab N. El Rayes, MD, PhD
10:08 am – 10:15 am
Dual Approach for DME: Findings from Faricimab
Dilsher S. Dhoot, MD
10:15 am – 10:22 am
Identifying Eyes that will Develop Vision Threatening Retinopathy
Patricia Udaondo, MD
10:22 am – 10:29 am
Long-term Outcomes of Anti-VEGF Therapy for Proliferative Diabetic Retinopathy: Year 5 Protocol S Outcomes
Jeffrey G. Gross, MD
10:29 am – 10:36 am
The Value of Treating Non-proliferative Diabetic Retinopathy
W. Lloyd Clark, MD
10:36 am – 10:43 am
Suprachoroidal Drug Delivery for Diabetic Macular Edema
Mark R. Barakat, MD
10:43 am – 10:50 am
Matching Diabetic Choroidopathy to Retinopathy: A Classification System of OCT Findings
Lilianne G. Duarte, MD, PgD
10:50 am – 10:57 am
Integrin Antagonism for DME
Hugo Quiroz-Mercado, MD
10:57 am – 11:04 am
Is There a Place for Lasers in the Management of Retinal Vascular Disease in the Anti-VEGF Era?
Victor H. Gonzalez, MD

Abstract Winners

11:04 am – 11:07 am
Reduction in Diabetic Retinal Neurodegeneration following 0.2µg/day FAc Implant: New Evidence from the USER Study
Alexander Eaton, MD
11:07 am – 11:10 am
Comparative Evaluation Of ASOCT, UBM and IOP after PRP by PASCAL or Conventional Laser in DR
Suman Iata, MD
11:10 am – 11:13 am
Suprachoroidal CLS-TA Plus Aflibercept Compared to Aflibercept Monotherapy for Diabetic Macular Edema: Results of the Randomized Phase 2 TYBEE Trial
Arshad Khanani, MD
11:13 am – 11:16 am
Abnormality of Foveal Avascular Zone Correlates with the Peripheral Retinal Ischemia in Diabetic Retinopathy
Aoi Kominami, MD
11:16 am – 11:19 am
Multicenter International Study: Biomarkers and Predictors for Functional and Anatomic Outcomes for Small Gauge Pars Plana Vitrectomy and Peeling of the Internal Limiting Membrane in Naïve Diabetic Macular Edema: The VITAL Study
Matias Iglicki, MD

Panel Discussion

11:25 am – 11:45 am
Medical Retina: Diabetic Macular Edema and Diabetic Retinopathy
Moderator: Peter K. Kaiser, MD
Panelists: Jerzy Nawrocki, MD, PhD; Acacio Muralha Neto, MD, MBA; Nelson A. Sabrosa, MD, PhD; Vaibhav Sethi, DNB, FLVPEI, FICO; Kiyoshi Suzuma, MD; Lihteh Wu, MD

CME LUNCH PROGRAM │ 12:00 pm – 1:00 pm

12:00 pm – 1:00 pm
Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery
Supported by Genentech, Inc.

GENERAL SESSIONS │ 1:15 pm – 5:30 pm

Controversies and Debates

Session Chairs: David R. Chow, MD, FRCSC; Pravin U. Dugel, MD; Jorge C.P. Rocha, MD, PhD; Lihteh Wu, MD
1:15 pm – 1:21 pm
Is Digitally Assisted Visualization Surgery Necessary for Surgery?
Pro: Flavio A. Rezende, MD, PhD
Con: Raja Narayanan, MD, MBA
1:21 pm – 1:26 pm
Questions & Answers
1:26 pm – 1:32 pm
Are Limit Internal Membrane Flaps Necessary for Macular Hole Surgery?
Pro: Anthanasios Nikolakopoulos, MD
Con: John W. Kitchens, MD
1:32 pm – 1:37 pm
Questions & Answers
1:37 pm – 1:43 pm
Is Intraoperative OCT Ready for Prime Time?
Pro: Susanne Binder, MD
Con: Magno A. Ferreira, MD, MsC, MBA, PhD
1:43 pm – 1:48 pm
Questions & Answers
1:48 pm – 1:54 pm
Is Scleral Buckling Still a Useful Technique?
Pro: Marcos P. Ávila, MD
Con: Fabio Patelli, MD
1:54 pm – 1:59 pm
Questions & Answers
1:59 pm – 2:05 pm
What is the First Line of Treatment for Macular Center Involved DME?
Steroids: Laurent Kodjikian, MD, PhD, FEBO
Anti-VEGF: Marcelo Zas, MD, PhD
2:05 pm – 2:10 pm
Questions & Answers
2:10 pm – 2:16 pm
Should Vitrectomy be the Primary Therapy for Endophthalmitis?
Pro: Ferenc Kuhn, MD, PhD
Con: William E. Smiddy, MD
2:16 pm – 2:21 pm
Questions & Answers
2:21 pm – 2:30 pm
What is the First Line of Treatment for Chronic CSCR?
PDT: Francesco Boscia, MD
Mineralocorticoid-receptor Antagonists: Francine Behar-Cohen, MD, PhD
Micropulse Laser: Jose A. Roca, MD
2:30 pm – 2:35 pm
Questions & Answers

Refreshment Break

2:35 pm – 2:55 pm
Refreshments in the Exhibit Hall

Controversies and Debates (Continued)

Session Chairs: David R. Chow, MD, FRCSC; Pravin U. Dugel, MD; Jorge C.P. Rocha, MD, PhD; Lihteh Wu, MD
2:55 pm – 3:01 pm
What is the First Line of Treatment for PCV?
PDT plus Anti-VEGF: Gregg T. Kokame, MD
Anti-VEGF Monotherapy: Leandro C. Zacharias, MD, PhD
3:01 pm – 3:06 pm
Questions & Answers
3:06 pm – 3:12 pm
Is Telemedicine for Ophthalmology Evaluations Ready for Prime Time?
Pro: Alexandre Taleb, MD, PhD
Con: Francisco J. Rodriguez, MD
3:12 pm – 3:17 pm
Questions & Answers
3:17 pm – 3:23 pm
Is Pneumatic Retinopexy Useful?
Pro: Rajeev H. Muni, MD, MSc, FRCSC
Con: Michael Kapusta, MD
3:23 pm – 3:28 pm
Questions & Answers

RETINAWS

Session Chairs: Arturo Alezzandrini, MD, PhD; Kourous A. Rezaei, MD; Taiji Sakamoto, MD, PhD
3:30 pm – 4:30 pm
Join us for a video-oriented surgical course where we’ll discuss complex vitreoretinal surgery, rare surgical cases and unique surgical techniques. Faculty from around the world will present on how they perform certain tasks and describe why they execute them the way do.
Panelists: Nur Acar Gocgil, MD, Prof, FEBO; Audina M. Berrocal, MD; Susanne Binder, MD; Francesco Boscia, MD; Carl C. Claes, MD; Jorge A. Fortun, MD; Motohiro Kamei, MD, PhD; Kiyoshi Suzuma, MD

Early Career Session

Session Moderators: Jorge A. Fortun, MD; Mitul C. Mehta, MD, MS; Hemang K. Pandya, MD
4:35 pm – 4:45 pm
Social Media for Collaboration: Young Retina Forum Survey Results
Hemang K. Pandya, MD
4:45 pm – 4:52 pm
How to Gain an Audience Outside of the Podium
Jayanth Sridhar, MD
4:52 pm – 4:59 pm
Getting Started with Clinical Research in Private Practice
Carl J. Danzig, MD
4:59 pm – 5:09 pm
Case Presentation
Yasha Modi, MD
5:09 pm – 5:19 pm
Case Presentation
Eduardo Uchiyama, MD
5:19 pm – 5:30 pm
International Collaboration
Carl Danzig, MD; Jorge A. Fortun, MD; Mitul C. Mehta, MD, MS; Raja Narayanan, MD, MBA; Hemang K. Pandya, MD; Yasha Modi, MD

SOCIAL RECEPTION* │ 7:00 pm – 10:00 pm

7:00 pm – 10:00 pm
Social Reception at LauderAle Brewery (see registration desk for assistance)
*This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™.